Comtech's Gilat deal confirms the ground-segment restructuring thesis while the Fundrise Innovation Fund's SpaceX-premium evaporation accelerates.

Comtech Telecommunications (CMTL) gained 8.3% to $2.99 after releasing Q3 fiscal 2026 results on June 15: net sales of $106M at a 34% gross margin, $8.2M adjusted EBITDA, $6.1M positive operating cash flow (the fifth consecutive quarter of positive cash generation), and — the embedded-value catalyst the pre-earnings trade was pricing — the announced sale of most of its Satellite and Space Communications business to Gilat Satellite Networks for $157.5M in cash ($143–145M net proceeds). The sale removes an underperforming, capital-intensive segment and leaves Comtech focused on its Allerium ground-infrastructure and government-services business with a $696M funded backlog. In the ground-segment chokepoint, Comtech is now a simpler, more solvent company: five straight quarters of positive cash flow from operations is a meaningful execution signal for a name that has traded near distressed levels.

VCX (Fundrise Innovation Fund) continued its post-IPO unwind, falling 16.4% to $91.99 — its worst session since listing — with SpaceX's recent IPO as the direct causal link. VCX held a material pre-IPO SpaceX stake as its anchor asset, and that position was the primary justification for the ~4× NAV premium at which the fund traded in April. SpaceX (SPCX) closed at $161 on its first trading day, up 19% from its $135 IPO price. Investors who wanted SpaceX exposure now hold SPCX directly. The NAV premium compression is mechanical and likely has further to go before the September 19, 2026 lockup expiry on pre-listing restricted shareholders adds supply. Space-sector investors holding VCX as an indirect launch/AI-satellite proxy should note that the underlying single-name alternatives — SPCX, RKLB, ASTS — are now fully liquid.

Karman Holdings (KRMN) was the session's second-best performer in the space basket, rising 7.1%, partially reversing a 52% three-month drawdown. Karman's precision propulsion and structural components occupy the propulsion-propellants chokepoint — it is a supplier to the launch stack, not a launch operator — and analyst buy ratings from RBC Capital (June 2) and Truist Securities (June 4) cited 20%-plus organic growth outlook and defense/space demand tailwinds. The stock participated in Truist's industrials conference on June 16, which may have given institutional investors cleaner access to management. Iridium (IRDM -0.8%) and Teledyne (TDY +0.3%) were near flat; both are insulated by recurring government-contract and satellite-services revenue from the IPO-rotation dynamics that pushed smaller-cap names around. BlackSky (BKSY -2.5%) and Planet Labs (PL -2.9%) extended modest post-SpaceX-IPO pressure as the Starshield commercial-imagery threat repricing continued.

The space vertical's next structural events: SPCX's first lock-up tranche (estimated ~August 21, approximately 70 days post-IPO) is the supply catalyst to watch; if insider selling materializes, the small-cap space proxies that fell on the IPO rotation could catch a partial reversal as passive SPCX flows normalize. Rocket Lab Q2 2026 earnings will be the first print with the Mynaric optical-terminal acquisition fully on the books — the read on whether laser inter-satellite links are converting to recognized revenue faster than RKLB's pre-IPO implied multiple. Comtech's Allerium backlog conversion and the Gilat transaction close timeline are the ground-segment checkpoints.